Monthly
US$200
Billed every month
米诺地尔搽剂
Companies, stages and changes, with each record available on this page.
Last 90 days: Marketing application approved: 1 applicationAccepted: 10 applicationsNo longer listed under review: 4 applicationsSupplement delivery: 1 applicationNotification delivery: 4 applications
Current coverage may be incomplete
Which companies are listed, and at what stages?
Each source is counted separately. Expand a list to inspect companies, identifiers, dates and sources.
Company names, approval identifiers and strengths are retained as recorded in the Chinese sources. Category labels include the original wording for verification.
Catalogue holders0View records ↓
Under-review filings51View records ↓
This year’s generic filers8View records ↓
NHSA approval numbers90View records ↓
API companies with A status16View records ↓
Chemical-drug catalogue
Loaded records: 0 holders; 0 in the quality-and-efficacy consistency-evaluation category, and 0 in the new chemical-registration-classification generic category. Category counts may overlap.
| Marketing authorization holder | Manufacturer | Approval number | Approved | Strength / specification | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| No matching records were found in the currently loaded source data; coverage dates are listed below. | ||||||
Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
NHSA drug codes
Loaded records: 90 distinct approval numbers and 56 companies.
| Company / applicant | Approval number | Strength / specification | NHSA class | NHSA drug code | View source |
|---|---|---|---|---|---|
| 乐福思健康产业股份公司 | 国药准字H20254833 | 5%(60毫升∶3.0克) | Not stated by source | XD11AXM104T001010100318 | NHSA |
| 杭州民生健康药业股份有限公司 | 国药准字H20253660 | 2%(60毫升:1.2克) | Not stated by source | XD11AXM104T001010100500 | NHSA |
| 沈阳三生制药有限责任公司 | 国药准字H20265680 | 2%(60毫升:1.2克) | Not stated by source | XD11AXM104T001010101313 | NHSA |
| 常州四药制药有限公司 | 国药准字H20253969 | 5%(60毫升:3.0克) | Not stated by source | XD11AXM104T001010101389 | NHSA |
| 江苏康缘药业股份有限公司 | 国药准字H20233226 | 5%(60毫升:3克) | Not stated by source | XD11AXM104T001010101463 | NHSA |
| 江苏润邦药业有限公司 | 国药准字H20253787 | 5%(60ml:3.0g) | Not stated by source | XD11AXM104T001010101475 | NHSA |
| 江苏神华药业有限公司 | 国药准字H20264966 | 2%(60ml:1.2g) | Not stated by source | XD11AXM104T001010101477 | NHSA |
| 江苏天士力帝益药业有限公司 | 国药准字H20263690 | 2%(60毫升 : 1.2克) | Not stated by source | XD11AXM104T001010101500 | NHSA |
| 江苏万高药业股份有限公司 | 国药准字H20243294 | 5%(60ml:3g) | Not stated by source | XD11AXM104T001010101503 | NHSA |
| 药大制药有限公司 | 国药准字H20263276 | 5%(60毫升:3.0克) | Not stated by source | XD11AXM104T001010101770 | NHSA |
| 远大医药(仙桃)制药有限公司 | 国药准字H20253551 | 2%(60毫升:1.2克) | Not stated by source | XD11AXM104T001010101862 | NHSA |
| 四川美大康华康药业有限公司 | 国药准字H20052642 | 100ml:2.0g | Not stated by source | XD11AXM104T001010102087 | NHSA |
| 四川科伦药业股份有限公司 | 国药准字H20253209 | 2%(60毫升︰1.2克) | Not stated by source | XD11AXM104T001010102180 | NHSA |
| 山西振东安欣生物制药有限公司 | 国药准字H20020190 | 60ml:1.2g | Not stated by source | XD11AXM104T001010102868 | NHSA |
| 太康海恩药业有限公司 | 国药准字H20263019 | 5%(60毫升:3.0克) | Not stated by source | XD11AXM104T001010103172 | NHSA |
| 乐泰药业(兰西)有限公司 | 国药准字H20256124 | 2%(60毫升:1.2克) | Not stated by source | XD11AXM104T001010103643 | NHSA |
| 鲁南贝特制药有限公司 | 国药准字H20243099 | 5%(60毫升︰3.0克) | Not stated by source | XD11AXM104T001010104010 | NHSA |
| 山东鲁抗医药集团赛特有限责任公司 | 国药准字H20263407 | 2%(60毫升:1.2克) | Not stated by source | XD11AXM104T001010104131 | NHSA |
| 山东新华制药股份有限公司 | 国药准字H20255139 | 5%(60毫升:3.0克) | Not stated by source | XD11AXM104T001010104187 | NHSA |
| 安徽省先锋制药有限公司 | 国药准字H20249389 | 2%(60毫升:1.2克) | Not stated by source | XD11AXM104T001010104339 | NHSA |
| 合肥华威药业有限公司 | 国药准字H20255037 | 2%(60毫升:1.2克) | Not stated by source | XD11AXM104T001010104388 | NHSA |
| 杭州康恩贝制药有限公司 | 国药准字H20249417 | 5%(60毫升:3.0克) | Not stated by source | XD11AXM104T001010104489 | NHSA |
| 浙江浙北药业有限公司 | 国药准字H20263305 | 2%(60毫升:1.2克) | Not stated by source | XD11AXM104T001010104755 | NHSA |
| 岳阳新华达制药有限公司 | 国药准字H20254011 | 5%(60毫升:3.0克) | Not stated by source | XD11AXM104T001010104918 | NHSA |
| 湖南千金湘江药业股份有限公司 | 国药准字H20265489 | 5%(60毫升:3.0克) | Not stated by source | XD11AXM104T001010104960 | NHSA |
| 江右制药(常德)有限公司 | 国药准字H20254406 | 2%(60毫升:1.2克) | Not stated by source | XD11AXM104T001010105031 | NHSA |
| 江西海尔思药业股份有限公司 | 国药准字H20264878 | 5%(60毫升:3.0克) | Not stated by source | XD11AXM104T001010105291 | NHSA |
| 浙江远力健药业有限责任公司 | 国药准字H20244586 | 2%(60毫升︰1.2克) | Not stated by source | XD11AXM104T001010109207 | NHSA |
| 丽彩甘肃西峰制药有限公司 | 国药准字H20244435 | 2%(60毫升:1.2克) | Not stated by source | XD11AXM104T001010109579 | NHSA |
| 中山万汉制药有限公司 | 国药准字H20243297 | 5%(60毫升:3.0克) | Not stated by source | XD11AXM104T001010109920 | NHSA |
| 江苏晨牌邦德药业有限公司 | 国药准字H20249808 | 2%(60毫升:1.2克) | Not stated by source | XD11AXM104T001010110112 | NHSA |
| 福元药业有限公司 | 国药准字H20253430 | 2%(60ml:1.2g) | Not stated by source | XD11AXM104T001010180651 | NHSA |
| 辽宁新高制药有限公司 | 国药准字H20255338 | 5%(60毫升:3.0克) | Not stated by source | XD11AXM104T001010181199 | NHSA |
| 江苏知原药业股份有限公司 | 国药准字H20254032 | 5%(60毫升:3.0克) | Not stated by source | XD11AXM104T001010181475 | NHSA |
| 沂南力诺制药有限责任公司 | 国药准字H20253678 | 5%(60毫升∶3.0克) | Not stated by source | XD11AXM104T001010183011 | NHSA |
| 山东华铂凯盛生物科技有限公司 | 国药准字H20263325 | 2%(60毫升︰1.2克) | Not stated by source | XD11AXM104T001010183034 | NHSA |
| 嘉实(湖南)医药科技有限公司 | 国药准字H20256384 | 5%(60毫升:3.0克) | Not stated by source | XD11AXM104T001010183048 | NHSA |
| 广州琥瑞医药科技发展有限公司 | 国药准字H20263521 | 5%(60毫升:3克) | Not stated by source | XD11AXM104T001010183642 | NHSA |
| 海南振东生物科技有限公司 | 国药准字H20244275 | 2%(60毫升:1.2克) | Not stated by source | XD11AXM104T001010183703 | NHSA |
| 江苏睿实生物科技有限公司 | 国药准字H20253979 | 2%(60ml∶1.2g) | Not stated by source | XD11AXM104T001010183832 | NHSA |
| 任曦医药科技河北有限公司 | 国药准字H20256089 | 5%(60毫升:3.0克) | Not stated by source | XD11AXM104T001010183846 | NHSA |
| 山东泰合医药科技有限公司 | 国药准字H20254396 | 2%(60毫升:1.2克) | Not stated by source | XD11AXM104T001010184043 | NHSA |
| 杭州沐源生物医药科技股份有限公司 | 国药准字H20243067 | 5%(60毫升︰3.0克) | Not stated by source | XD11AXM104T001010184135 | NHSA |
| 山东福瑞达医药集团有限公司 | 国药准字H20244724 | 2%(60毫升︰1.2克) | Not stated by source | XD11AXM104T001010184211 | NHSA |
| 浙江高跖医药科技股份有限公司 | 国药准字H20254134 | 5%(60毫升:3.0克) | Not stated by source | XD11AXM104T001010184221 | NHSA |
| 宁波美舒药业有限公司 | 国药准字H20244727 | 2%(60毫升:1.2克) | Not stated by source | XD11AXM104T001010184223 | NHSA |
| 圣嘉(滨海)生物医药科技有限公司 | 国药准字H20255533 | 5%(60毫升:3.0克) | Not stated by source | XD11AXM104T001010184450 | NHSA |
| 北京博喆研医药科技有限公司 | 国药准字H20253675 | 5%(60毫升:3.0克) | Not stated by source | XD11AXM104T001010184612 | NHSA |
| 北京诺博特生物科技有限公司 | 国药准字H20255541 | 5%(60毫升︰3.0克) | Not stated by source | XD11AXM104T001010184613 | NHSA |
| 济南中海医药科技有限公司 | 国药准字H20249312 | 2%(60毫升:1.2克) | Not stated by source | XD11AXM104T001010184624 | NHSA |
| 深圳市朗博生物医药股份有限公司 | 国药准字H20253978 | 5%(60 毫升:3.0 克) | Not stated by source | XD11AXM104T001010184694 | NHSA |
| 广东泉新泉益药业有限公司 | 国药准字H20253973 | 2%(60ml:1.2g) | Not stated by source | XD11AXM104T001010184701 | NHSA |
| 河北义海医药科技有限公司 | 国药准字H20264374 | 5%(60毫升:3.0克) | Not stated by source | XD11AXM104T001010185039 | NHSA |
| 合肥远志医药科技开发有限公司 | 国药准字H20265912 | 5%(60毫升:3.0克) | Not stated by source | XD11AXM104T001010185197 | NHSA |
| 武汉华尔生物科技有限公司 | 国药准字H20264582 | 2%(60毫升:1.2克) | Not stated by source | XD11AXM104T001010185564 | NHSA |
| 沈阳三生制药有限责任公司 | 国药准字H20265680 | 2%(60毫升:1.2克) | Not stated by source | XD11AXM104T001010201313 | NHSA |
| 常州四药制药有限公司 | 国药准字H20253969 | 5%(60毫升:3.0克) | Not stated by source | XD11AXM104T001010201389 | NHSA |
| 江苏润邦药业有限公司 | 国药准字H20253787 | 5%(60ml:3.0g) | Not stated by source | XD11AXM104T001010201475 | NHSA |
| 远大医药(仙桃)制药有限公司 | 国药准字H20253551 | 2%(60毫升:1.2克) | Not stated by source | XD11AXM104T001010201862 | NHSA |
| 安徽省先锋制药有限公司 | 国药准字H20249389 | 2%(60毫升:1.2克) | Not stated by source | XD11AXM104T001010204339 | NHSA |
| 岳阳新华达制药有限公司 | 国药准字H20254011 | 5%(60毫升:3.0克) | Not stated by source | XD11AXM104T001010204918 | NHSA |
| 丽彩甘肃西峰制药有限公司 | 国药准字H20244435 | 2%(60毫升:1.2克) | Not stated by source | XD11AXM104T001010209579 | NHSA |
| 海南振东生物科技有限公司 | 国药准字H20244275 | 2%(60毫升:1.2克) | Not stated by source | XD11AXM104T001010283703 | NHSA |
| 江苏睿实生物科技有限公司 | 国药准字H20253979 | 2%(60ml∶1.2g) | Not stated by source | XD11AXM104T001010283832 | NHSA |
| 任曦医药科技河北有限公司 | 国药准字H20256089 | 5%(60毫升:3.0克) | Not stated by source | XD11AXM104T001010283846 | NHSA |
| 山东泰合医药科技有限公司 | 国药准字H20254396 | 2%(60毫升:1.2克) | Not stated by source | XD11AXM104T001010284043 | NHSA |
| 山东福瑞达医药集团有限公司 | 国药准字H20244724 | 2%(60毫升︰1.2克) | Not stated by source | XD11AXM104T001010284211 | NHSA |
| 合肥远志医药科技开发有限公司 | 国药准字H20265912 | 5%(60毫升:3.0克) | Not stated by source | XD11AXM104T001010285197 | NHSA |
| 沈阳三生制药有限责任公司 | 国药准字H20265680 | 2%(60毫升:1.2克) | Not stated by source | XD11AXM104T001010301313 | NHSA |
| 江苏润邦药业有限公司 | 国药准字H20253787 | 5%(60ml:3.0g) | Not stated by source | XD11AXM104T001010301475 | NHSA |
| 安徽省先锋制药有限公司 | 国药准字H20249389 | 2%(60毫升:1.2克) | Not stated by source | XD11AXM104T001010304339 | NHSA |
| 丽彩甘肃西峰制药有限公司 | 国药准字H20244435 | 2%(60毫升:1.2克) | Not stated by source | XD11AXM104T001010309579 | NHSA |
| 江苏睿实生物科技有限公司 | 国药准字H20253979 | 2%(60ml∶1.2g) | Not stated by source | XD11AXM104T001010383832 | NHSA |
| 山东泰合医药科技有限公司 | 国药准字H20254396 | 2%(60毫升:1.2克) | Not stated by source | XD11AXM104T001010384043 | NHSA |
| 山东福瑞达医药集团有限公司 | 国药准字H20244724 | 2%(60毫升︰1.2克) | Not stated by source | XD11AXM104T001010384211 | NHSA |
| 合肥远志医药科技开发有限公司 | 国药准字H20265912 | 5%(60毫升:3.0克) | Not stated by source | XD11AXM104T001010385197 | NHSA |
| 江苏润邦药业有限公司 | 国药准字H20253787 | 5%(60ml:3.0g) | Not stated by source | XD11AXM104T001010401475 | NHSA |
| 安徽省先锋制药有限公司 | 国药准字H20249389 | 2%(60毫升:1.2克) | Not stated by source | XD11AXM104T001010404339 | NHSA |
| 江苏润邦药业有限公司 | 国药准字H20253787 | 5%(60ml:3.0g) | Not stated by source | XD11AXM104T001010501475 | NHSA |
| 安徽省先锋制药有限公司 | 国药准字H20249389 | 2%(60毫升:1.2克) | Not stated by source | XD11AXM104T001010504339 | NHSA |
| 江苏润邦药业有限公司 | 国药准字H20253787 | 5%(60ml:3.0g) | Not stated by source | XD11AXM104T001010601475 | NHSA |
| 安徽省先锋制药有限公司 | 国药准字H20249389 | 2%(60毫升:1.2克) | Not stated by source | XD11AXM104T001010604339 | NHSA |
| 杭州民生健康药业股份有限公司 | 国药准字H20253661 | 5%(60毫升:3.0克) | Not stated by source | XD11AXM104T001020100500 | NHSA |
| 沈阳三生制药有限责任公司 | 国药准字H20265681 | 5%(60毫升:3.0克) | Not stated by source | XD11AXM104T001020101313 | NHSA |
| 江苏神华药业有限公司 | 国药准字H20264967 | 5%(60ml︰3.0g) | Not stated by source | XD11AXM104T001020101477 | NHSA |
| 江苏天士力帝益药业有限公司 | 国药准字H20263691 | 5%(60毫升 : 3.0克) | Not stated by source | XD11AXM104T001020101500 | NHSA |
| 江苏万高药业股份有限公司 | 国药准字H20243293 | 2%(60ml:1.2g) | Not stated by source | XD11AXM104T001020101503 | NHSA |
| 远大医药(仙桃)制药有限公司 | 国药准字H20253552 | 5%(60毫升:3.0克) | Not stated by source | XD11AXM104T001020101862 | NHSA |
| 四川美大康华康药业有限公司 | 国药准字H20052642 | 100ml:2.0g | Not stated by source | XD11AXM104T001020102087 | NHSA |
| 四川科伦药业股份有限公司 | 国药准字H20253210 | 5%(60毫升:3.0克) | Not stated by source | XD11AXM104T001020102180 | NHSA |
| 山西振东安欣生物制药有限公司 | 国药准字H20020190 | 60ml:1.2g | Not stated by source | XD11AXM104T001020102868 | NHSA |
| 乐泰药业(兰西)有限公司 | 国药准字H20256125 | 5%(60毫升:3.0克) | Not stated by source | XD11AXM104T001020103643 | NHSA |
| 鲁南贝特制药有限公司 | 国药准字H20244460 | 2%(60毫升1.2克) | Not stated by source | XD11AXM104T001020104010 | NHSA |
| 山东鲁抗医药集团赛特有限责任公司 | 国药准字H20263408 | 5%(60毫升:3.0克) | Not stated by source | XD11AXM104T001020104131 | NHSA |
| 安徽省先锋制药有限公司 | 国药准字H20249390 | 5%(60毫升:3.0克) | Not stated by source | XD11AXM104T001020104339 | NHSA |
| 合肥华威药业有限公司 | 国药准字H20255038 | 5%(60毫升:3.0克) | Not stated by source | XD11AXM104T001020104388 | NHSA |
| 杭州康恩贝制药有限公司 | 国药准字H20249454 | 2%(60毫升∶1.2克) | Not stated by source | XD11AXM104T001020104489 | NHSA |
| 浙江浙北药业有限公司 | 国药准字H20263306 | 5%(60毫升:3.0克) | Not stated by source | XD11AXM104T001020104755 | NHSA |
| 江右制药(常德)有限公司 | 国药准字H20254407 | 5%(60毫升:3.0克) | Not stated by source | XD11AXM104T001020105031 | NHSA |
| 江西海尔思药业股份有限公司 | 国药准字H20264878 | 5%(60毫升:3.0克) | Not stated by source | XD11AXM104T001020105291 | NHSA |
| 浙江远力健药业有限责任公司 | 国药准字H20249221 | 5%(60毫升︰3.0克) | Not stated by source | XD11AXM104T001020109207 | NHSA |
| 丽彩甘肃西峰制药有限公司 | 国药准字H20244436 | 5%(60毫升:3.0克) | Not stated by source | XD11AXM104T001020109579 | NHSA |
| 中山万汉制药有限公司 | 国药准字H20243296 | 2%(60毫升:1.2克) | Not stated by source | XD11AXM104T001020109920 | NHSA |
| 福元药业有限公司 | 国药准字H20253431 | 5%(60ml:3.0g) | Not stated by source | XD11AXM104T001020180651 | NHSA |
| 辽宁新高制药有限公司 | 国药准字H20255338 | 5%(60毫升:3.0克) | Not stated by source | XD11AXM104T001020181199 | NHSA |
| 江苏知原药业股份有限公司 | 国药准字H20254033 | 2%(60毫升:1.2克) | Not stated by source | XD11AXM104T001020181475 | NHSA |
| 山东华铂凯盛生物科技有限公司 | 国药准字H20263326 | 5%(60ml:3.0g) | Not stated by source | XD11AXM104T001020183034 | NHSA |
| 广州琥瑞医药科技发展有限公司 | 国药准字H20263522 | 2%(60毫升:1.2克) | Not stated by source | XD11AXM104T001020183642 | NHSA |
| 海南振东生物科技有限公司 | 国药准字H20244276 | 5%(60毫升:3.0克) | Not stated by source | XD11AXM104T001020183703 | NHSA |
| 江苏睿实生物科技有限公司 | 国药准字H20253980 | 5%(60ml∶3.0g) | Not stated by source | XD11AXM104T001020183832 | NHSA |
| 山东泰合医药科技有限公司 | 国药准字H20254397 | 5%(60毫升:3.0克) | Not stated by source | XD11AXM104T001020184043 | NHSA |
| 山东福瑞达医药集团有限公司 | 国药准字H20244749 | 5%(60毫升:3克) | Not stated by source | XD11AXM104T001020184211 | NHSA |
| 宁波美舒药业有限公司 | 国药准字H20244728 | 5%(60毫升:3.0克) | Not stated by source | XD11AXM104T001020184223 | NHSA |
| 北京博喆研医药科技有限公司 | 国药准字H20253675 | 5%(60毫升:3.0克) | Not stated by source | XD11AXM104T001020184612 | NHSA |
| 北京诺博特生物科技有限公司 | 国药准字H20255542 | 2%(60毫升︰1.2克) | Not stated by source | XD11AXM104T001020184613 | NHSA |
| 济南中海医药科技有限公司 | 国药准字H20249313 | 5%(60毫升:3克) | Not stated by source | XD11AXM104T001020184624 | NHSA |
| 广东泉新泉益药业有限公司 | 国药准字H20253974 | 5%(60ml:3.0g) | Not stated by source | XD11AXM104T001020184701 | NHSA |
| 河北义海医药科技有限公司 | 国药准字H20264375 | 2%(60毫升:1.2克) | Not stated by source | XD11AXM104T001020185039 | NHSA |
| 沈阳三生制药有限责任公司 | 国药准字H20265681 | 5%(60毫升:3.0克) | Not stated by source | XD11AXM104T001020201313 | NHSA |
| 远大医药(仙桃)制药有限公司 | 国药准字H20253552 | 5%(60毫升:3.0克) | Not stated by source | XD11AXM104T001020201862 | NHSA |
| 安徽省先锋制药有限公司 | 国药准字H20249390 | 5%(60毫升:3.0克) | Not stated by source | XD11AXM104T001020204339 | NHSA |
| 浙江远力健药业有限责任公司 | 国药准字H20249221 | 5%(60毫升︰3.0克) | Not stated by source | XD11AXM104T001020209207 | NHSA |
| 丽彩甘肃西峰制药有限公司 | 国药准字H20244436 | 5%(60毫升:3.0克) | Not stated by source | XD11AXM104T001020209579 | NHSA |
| 海南振东生物科技有限公司 | 国药准字H20244276 | 5%(60毫升:3.0克) | Not stated by source | XD11AXM104T001020283703 | NHSA |
| 江苏睿实生物科技有限公司 | 国药准字H20253980 | 5%(60ml∶3.0g) | Not stated by source | XD11AXM104T001020283832 | NHSA |
| 山东泰合医药科技有限公司 | 国药准字H20254397 | 5%(60毫升:3.0克) | Not stated by source | XD11AXM104T001020284043 | NHSA |
| 山东福瑞达医药集团有限公司 | 国药准字H20244749 | 5%(60毫升:3克) | Not stated by source | XD11AXM104T001020284211 | NHSA |
| 北京博喆研医药科技有限公司 | 国药准字H20253675 | 5%(60毫升:3.0克) | Not stated by source | XD11AXM104T001020284612 | NHSA |
| 沈阳三生制药有限责任公司 | 国药准字H20265681 | 5%(60毫升:3.0克) | Not stated by source | XD11AXM104T001020301313 | NHSA |
| 安徽省先锋制药有限公司 | 国药准字H20249390 | 5%(60毫升:3.0克) | Not stated by source | XD11AXM104T001020304339 | NHSA |
| 丽彩甘肃西峰制药有限公司 | 国药准字H20244436 | 5%(60毫升:3.0克) | Not stated by source | XD11AXM104T001020309579 | NHSA |
| 江苏睿实生物科技有限公司 | 国药准字H20253980 | 5%(60ml∶3.0g) | Not stated by source | XD11AXM104T001020383832 | NHSA |
| 山东泰合医药科技有限公司 | 国药准字H20254397 | 5%(60毫升:3.0克) | Not stated by source | XD11AXM104T001020384043 | NHSA |
| 山东福瑞达医药集团有限公司 | 国药准字H20244749 | 5%(60毫升:3克) | Not stated by source | XD11AXM104T001020384211 | NHSA |
| 北京博喆研医药科技有限公司 | 国药准字H20253675 | 5%(60毫升:3.0克) | Not stated by source | XD11AXM104T001020384612 | NHSA |
| 安徽省先锋制药有限公司 | 国药准字H20249390 | 5%(60毫升:3.0克) | Not stated by source | XD11AXM104T001020404339 | NHSA |
| 北京博喆研医药科技有限公司 | 国药准字H20253675 | 5%(60毫升:3.0克) | Not stated by source | XD11AXM104T001020484612 | NHSA |
| 安徽省先锋制药有限公司 | 国药准字H20249390 | 5%(60毫升:3.0克) | Not stated by source | XD11AXM104T001020504339 | NHSA |
| 北京博喆研医药科技有限公司 | 国药准字H20253675 | 5%(60毫升:3.0克) | Not stated by source | XD11AXM104T001020584612 | NHSA |
| 安徽省先锋制药有限公司 | 国药准字H20249390 | 5%(60毫升:3.0克) | Not stated by source | XD11AXM104T001020604339 | NHSA |
| 北京博喆研医药科技有限公司 | 国药准字H20253675 | 5%(60毫升:3.0克) | Not stated by source | XD11AXM104T001020684612 | NHSA |
| 北京博喆研医药科技有限公司 | 国药准字H20253675 | 5%(60毫升:3.0克) | Not stated by source | XD11AXM104T001020784612 | NHSA |
| 江苏济茗医药有限公司 | 国药准字H20263842 | 5%(60毫升:3.0克) | Not stated by source | XD11AXM104T001030101503 | NHSA |
| 四川美大康华康药业有限公司 | 国药准字H20052642 | 100ml:2.0g | Not stated by source | XD11AXM104T001030102087 | NHSA |
| 山西振东安欣生物制药有限公司 | 国药准字H20060626 | 60ml:3g | Not stated by source | XD11AXM104T001030102868 | NHSA |
| 杭州康恩贝制药有限公司 | 国药准字H20249417 | 5%(60毫升:3.0克) | Not stated by source | XD11AXM104T001030104489 | NHSA |
| 广东泉新泉益药业有限公司 | 国药准字H20253974 | 5%(60ml:3.0g) | Not stated by source | XD11AXM104T001030184701 | NHSA |
| 广东泉新泉益药业有限公司 | 国药准字H20253974 | 5%(60ml:3.0g) | Not stated by source | XD11AXM104T001030284701 | NHSA |
| 广东泉新泉益药业有限公司 | 国药准字H20253974 | 5%(60ml:3.0g) | Not stated by source | XD11AXM104T001030384701 | NHSA |
| 广东泉新泉益药业有限公司 | 国药准字H20253974 | 5%(60ml:3.0g) | Not stated by source | XD11AXM104T001030484701 | NHSA |
| 江苏济茗医药有限公司 | 国药准字H20263841 | 2%(60毫升:1.2克) | Not stated by source | XD11AXM104T001040101503 | NHSA |
| 四川美大康华康药业有限公司 | 国药准字H20052642 | 100ml:2.0g | Not stated by source | XD11AXM104T001040102087 | NHSA |
| 山西振东安欣生物制药有限公司 | 国药准字H20060626 | 60ml:3g | Not stated by source | XD11AXM104T001040102868 | NHSA |
| 广东泉新泉益药业有限公司 | 国药准字H20253974 | 5%(60ml:3.0g) | Not stated by source | XD11AXM104T001040184701 | NHSA |
| 四川美大康华康药业有限公司 | 国药准字H20052642 | 100ml:2.0g | Not stated by source | XD11AXM104T001050102087 | NHSA |
| 山西振东安欣生物制药有限公司 | 国药准字H20060626 | 60ml:3g | Not stated by source | XD11AXM104T001050102868 | NHSA |
| 广东泉新泉益药业有限公司 | 国药准字H20253974 | 5%(60ml:3.0g) | Not stated by source | XD11AXM104T001050184701 | NHSA |
| 四川美大康华康药业有限公司 | 国药准字H20269019 | 5%(60ml:3.0g) | Not stated by source | XD11AXM104T001060102087 | NHSA |
| 山西振东安欣生物制药有限公司 | 国药准字H20060626 | 60ml:3g | Not stated by source | XD11AXM104T001060102868 | NHSA |
| 广东泉新泉益药业有限公司 | 国药准字H20253974 | 5%(60ml:3.0g) | Not stated by source | XD11AXM104T001060184701 | NHSA |
| 四川美大康华康药业有限公司 | 国药准字H20269019 | 5%(60ml:3.0g) | Not stated by source | XD11AXM104T001060202087 | NHSA |
| 山西振东安欣生物制药有限公司 | 国药准字H20020190 | 60ml:1.2g | Not stated by source | XD11AXM104T001060202868 | NHSA |
| 山西振东安欣生物制药有限公司 | 国药准字H20020190 | 60ml:1.2g | Not stated by source | XD11AXM104T001070102868 | NHSA |
| 广东泉新泉益药业有限公司 | 国药准字H20253974 | 5%(60ml:3.0g) | Not stated by source | XD11AXM104T001070184701 | NHSA |
Approval numbers and companies are deduplicated separately; packaging records remain individually listed. An empty insurance class means it is unstated. NHSA codes supply no approval date and do not establish the outcome of an acceptance number.
Current under-review applications
Loaded records: 51 filings and 29 distinct first applicants.
Generic 42 · Supplement 9
| Company / applicant | Acceptance number | Application type | Accepted | Strength / specification | View source |
|---|---|---|---|---|---|
| 山东诺明康药物研究院有限公司;烟台鲁银药业有限公司 | CYHS2501712 | Generic | 2025/05/12 | Not stated by source | CDE |
| 山东诺明康药物研究院有限公司;烟台鲁银药业有限公司 | CYHS2501711 | Generic | 2025/05/12 | Not stated by source | CDE |
| 深圳市朗博生物医药股份有限公司;江苏知原药业股份有限公司 | CYHB2601512 | Supplement | 2026/08/07 | Not stated by source | CDE |
| 江苏福邦药业有限公司 | CYHS2501965 | Generic | 2025/06/04 | Not stated by source | CDE |
| 江苏希尔生药业有限公司;江苏迪赛诺制药有限公司 | CYHS2503869 | Generic | 2025/11/05 | Not stated by source | CDE |
| 江苏希尔生药业有限公司;江苏迪赛诺制药有限公司 | CYHS2503868 | Generic | 2025/11/05 | Not stated by source | CDE |
| 南京恩泰医药科技有限公司;合肥华威药业有限公司 | CYHS2504222 | Generic | 2025/12/09 | Not stated by source | CDE |
| 南京恩泰医药科技有限公司;合肥华威药业有限公司 | CYHS2504221 | Generic | 2025/12/09 | Not stated by source | CDE |
| 科笛生物医药（无锡）有限公司 | CYHS2502500 | Generic | 2025/07/12 | Not stated by source | CDE |
| 科笛生物医药（无锡）有限公司 | CYHS2502499 | Generic | 2025/07/12 | Not stated by source | CDE |
| 江苏鹏鹞药业有限公司 | CYHS2602200 | Generic | 2026/09/03 | Not stated by source | CDE |
| 江苏鹏鹞药业有限公司 | CYHS2602199 | Generic | 2026/09/03 | Not stated by source | CDE |
| 杭州民生健康药业股份有限公司;浙江赛默制药有限公司 | CYHB2601814 | Supplement | 2026/09/24 | Not stated by source | CDE |
| 杭州民生健康药业股份有限公司;浙江赛默制药有限公司 | CYHB2601813 | Supplement | 2026/09/24 | Not stated by source | CDE |
| 天方药业有限公司;浙江赛默制药有限公司 | CYHB2601538 | Supplement | 2026/08/12 | Not stated by source | CDE |
| 天方药业有限公司;浙江赛默制药有限公司 | CYHB2601537 | Supplement | 2026/08/12 | Not stated by source | CDE |
| 中山百灵生物技术股份有限公司;中山万汉制药有限公司 | CYHS2601811 | Generic | 2026/07/28 | Not stated by source | CDE |
| 正大天晴药业集团股份有限公司;广东科泓药业有限公司 | CYHS2601676 | Generic | 2026/07/14 | Not stated by source | CDE |
| 正大天晴药业集团股份有限公司;广东科泓药业有限公司 | CYHS2601675 | Generic | 2026/07/14 | Not stated by source | CDE |
| 安徽得宏生制药有限公司;浙江鼎泰药业股份有限公司 | CYHS2601529 | Generic | 2026/06/29 | Not stated by source | CDE |
| 湖北长江瑞益医药科技有限公司;远大医药（仙桃）制药有限公司 | CYHS2601475 | Generic | 2026/06/23 | Not stated by source | CDE |
| 湖北长江瑞益医药科技有限公司;远大医药（仙桃）制药有限公司 | CYHS2601474 | Generic | 2026/06/23 | Not stated by source | CDE |
| 湖北康正药业有限公司 | CYHS2601401 | Generic | 2026/06/12 | Not stated by source | CDE |
| 湖北康正药业有限公司 | CYHS2601400 | Generic | 2026/06/12 | Not stated by source | CDE |
| 杭州万邦天诚药业有限公司 | CYHS2600537 | Generic | 2026/02/26 | Not stated by source | CDE |
| 山东健滨医药科技有限公司;上海理想制药有限公司 | CYHS2600286 | Generic | 2026/01/27 | Not stated by source | CDE |
| 山东健滨医药科技有限公司;上海理想制药有限公司 | CYHS2600285 | Generic | 2026/01/27 | Not stated by source | CDE |
| 保定天浩制药有限公司 | CYHS2504247 | Generic | 2025/12/11 | Not stated by source | CDE |
| 保定天浩制药有限公司 | CYHS2504246 | Generic | 2025/12/11 | Not stated by source | CDE |
| 湖南九典制药股份有限公司;杭州万邦天诚药业有限公司 | CYHS2504171 | Generic | 2025/12/05 | Not stated by source | CDE |
| 翔宇药业股份有限公司 | CYHS2503730 | Generic | 2025/10/18 | Not stated by source | CDE |
| 翔宇药业股份有限公司 | CYHS2503729 | Generic | 2025/10/18 | Not stated by source | CDE |
| 唐山红星药业有限责任公司 | CYHS2503551 | Generic | 2025/09/28 | Not stated by source | CDE |
| 唐山红星药业有限责任公司 | CYHS2503550 | Generic | 2025/09/28 | Not stated by source | CDE |
| 海南钧华医疗科技有限公司;北京京丰制药（河北）有限公司 | CYHS2503477 | Generic | 2025/09/20 | Not stated by source | CDE |
| 四川依科制药有限公司 | CYHS2503268 | Generic | 2025/09/05 | Not stated by source | CDE |
| 四川依科制药有限公司 | CYHS2503266 | Generic | 2025/09/05 | Not stated by source | CDE |
| 湖北午时药业股份有限公司 | CYHS2502494 | Generic | 2025/07/12 | Not stated by source | CDE |
| 湖北午时药业股份有限公司 | CYHS2502493 | Generic | 2025/07/12 | Not stated by source | CDE |
| 山东朗诺制药有限公司;广东科泓药业有限公司 | CYHS2502003 | Generic | 2025/06/06 | Not stated by source | CDE |
| 山东朗诺制药有限公司;广东科泓药业有限公司 | CYHS2502002 | Generic | 2025/06/06 | Not stated by source | CDE |
| 广东科泓药业有限公司 | CYHS2501714 | Generic | 2025/05/12 | Not stated by source | CDE |
| 广东科泓药业有限公司 | CYHS2501713 | Generic | 2025/05/12 | Not stated by source | CDE |
| 长沙创新药物工业技术研究院有限公司;广东科泓药业有限公司 | CYHS2501671 | Generic | 2025/05/08 | Not stated by source | CDE |
| 长沙创新药物工业技术研究院有限公司;广东科泓药业有限公司 | CYHS2501670 | Generic | 2025/05/08 | Not stated by source | CDE |
| 北京京丰制药（山东）有限公司 | CYHS2500598 | Generic | 2025/02/07 | Not stated by source | CDE |
| 北京京丰制药（山东）有限公司 | CYHS2500597 | Generic | 2025/02/07 | Not stated by source | CDE |
| 江苏润邦药业有限公司;中山万汉制药有限公司 | CYHB2601964 | Supplement | 2026/10/27 | Not stated by source | CDE |
| 江苏润邦药业有限公司;中山万汉制药有限公司 | CYHB2601963 | Supplement | 2026/10/27 | Not stated by source | CDE |
| 海南海神同洲制药有限公司;合肥华威药业有限公司 | CYHB2602031 | Supplement | 2026/11/09 | Not stated by source | CDE |
| 海南海神同洲制药有限公司;合肥华威药业有限公司 | CYHB2602030 | Supplement | 2026/11/09 | Not stated by source | CDE |
New generic filings in 2026
Loaded records: 13 filings and 8 distinct first applicants.
| Company / applicant | Acceptance number | Application type | Accepted | Strength / specification | View source |
|---|---|---|---|---|---|
| 江苏鹏鹞药业有限公司 | CYHS2602200 | Generic | 2026/09/03 | Not stated by source | CDE |
| 江苏鹏鹞药业有限公司 | CYHS2602199 | Generic | 2026/09/03 | Not stated by source | CDE |
| 中山百灵生物技术股份有限公司;中山万汉制药有限公司 | CYHS2601811 | Generic | 2026/07/28 | Not stated by source | CDE |
| 正大天晴药业集团股份有限公司;广东科泓药业有限公司 | CYHS2601676 | Generic | 2026/07/14 | Not stated by source | CDE |
| 正大天晴药业集团股份有限公司;广东科泓药业有限公司 | CYHS2601675 | Generic | 2026/07/14 | Not stated by source | CDE |
| 安徽得宏生制药有限公司;浙江鼎泰药业股份有限公司 | CYHS2601529 | Generic | 2026/06/29 | Not stated by source | CDE |
| 湖北长江瑞益医药科技有限公司;远大医药（仙桃）制药有限公司 | CYHS2601475 | Generic | 2026/06/23 | Not stated by source | CDE |
| 湖北长江瑞益医药科技有限公司;远大医药（仙桃）制药有限公司 | CYHS2601474 | Generic | 2026/06/23 | Not stated by source | CDE |
| 湖北康正药业有限公司 | CYHS2601401 | Generic | 2026/06/12 | Not stated by source | CDE |
| 湖北康正药业有限公司 | CYHS2601400 | Generic | 2026/06/12 | Not stated by source | CDE |
| 杭州万邦天诚药业有限公司 | CYHS2600537 | Generic | 2026/02/26 | Not stated by source | CDE |
| 山东健滨医药科技有限公司;上海理想制药有限公司 | CYHS2600286 | Generic | 2026/01/27 | Not stated by source | CDE |
| 山东健滨医药科技有限公司;上海理想制药有限公司 | CYHS2600285 | Generic | 2026/01/27 | Not stated by source | CDE |
API registrations
Non-component matches: 16 companies with A status and 4 I-status records. Component matches are listed separately and excluded from these counts.
| Name | Company / applicant | Registration number | Status | Name match | Source update date | View source |
|---|---|---|---|---|---|---|
| 米诺地尔 | 浙江先锋科技集团股份有限公司 | Y20260000654 | I | Exact ingredient | 2026/08/31 | CDE |
| 米诺地尔 | 中山百盛生物技术有限公司 | Y20260000153 | I | Exact ingredient | 2026/03/09 | CDE |
| 米诺地尔 | 山东济坤生物制药有限公司 | Y20250001475 | I | Exact ingredient | 2026/01/07 | CDE |
| 米诺地尔 | 鹤壁市信和药业有限公司 | Y20250000583 | I | Exact ingredient | 2025/07/01 | CDE |
| 米诺地尔 | 辽宁红珊瑚药业有限公司 | Y20250000348 | A | Exact ingredient | 2026/08/28 | CDE |
| 米诺地尔 | 山东锐顺药业有限公司 | Y20240001177 | A | Exact ingredient | 2026/06/18 | CDE |
| 米诺地尔 | 福建南方制药股份有限公司 | Y20240000460 | A | Exact ingredient | 2025/11/28 | CDE |
| 米诺地尔 | 四川美大康华康药业有限公司 | Y20240000123 | A | Exact ingredient | 2025/12/31 | CDE |
| 米诺地尔 | VPL CHEMICALS PRIVATE LIMITED | Y20230000589 | A | Exact ingredient | 2025/12/29 | CDE |
| 米诺地尔 | 山西振东泰盛制药有限公司 | Y20230000847 | A | Exact ingredient | 2025/02/22 | CDE |
| 米诺地尔 | 浙江赛默制药有限公司 | Y20230000415 | A | Exact ingredient | 2026/03/27 | CDE |
| 米诺地尔 | 天科（荆州）制药有限公司 | Y20220001342 | A | Exact ingredient | 2026/03/13 | CDE |
| 米诺地尔 | 启东东岳药业有限公司 | Y20220000673 | A | Exact ingredient | 2024/04/16 | CDE |
| 米诺地尔 | 中山万汉制药有限公司 | Y20220000201 | A | Exact ingredient | 2025/11/21 | CDE |
| 米诺地尔 | Kumar Organic Products Ltd. | Y20200001457 | A | Exact ingredient | 2024/02/08 | CDE |
| 米诺地尔 | 常州金晟制药厂 | Y20200000808 | A | Exact ingredient | 2024/11/07 | CDE |
| 米诺地尔 | 常州四药制药有限公司 | Y20190004912 | A | Exact ingredient | 2025/11/22 | CDE |
| 米诺地尔 | 天津药物研究院药业有限责任公司 | Y20190002654 | A | Exact ingredient | 2024/12/19 | CDE |
| 米诺地尔 | 富乐马鸿凯（大连）医药有限公司 | Y20190000309 | A | Exact ingredient | 2025/10/29 | CDE |
| 米诺地尔 | Flamma S.p.A | Y20180001649 | A | Exact ingredient | 2024/10/30 | CDE |
A/I are source statuses. Matching uses exact ingredients, salt-normalized names and maintained combination components, without fuzzy matching. A-status companies are deduplicated by the first registered company. Components are excluded from headline counts; the register does not identify the associated formulation.
What changed recently?
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately.
Trial registration does not mean an application will follow.
This product is outside the trial-registration backfill scope. New registrations after daily collection started remain in scope. Historical rows may also be found by another product search; neither implies complete historical coverage for this product.
NHSA edition maintained to 2026-10-23; latest successful catalogue check: 2026/11/10 07:23. NHSA records lack approval dates; only an earlier edition or observation establishes precedence.
-
2026/11/09Supplement delivery
深圳市朗博生物医药股份有限公司
CYHB2601512
Fact date: 2026/11/09 · Publication date: 2026/11/10 · Site observation date: 2026/11/10
Supplemental application; excluded from new marketing approvals.
View source · Table row 18 ↗ -
2026/11/09Accepted
海南海神同洲制药有限公司;合肥华威药业有限公司
CYHB2602031
Fact date: 2026/11/09 · Site observation date: 2026/11/10
View source ↗ -
2026/11/09Accepted
海南海神同洲制药有限公司;合肥华威药业有限公司
CYHB2602030
Fact date: 2026/11/09 · Site observation date: 2026/11/10
View source ↗ -
2026/11/03Marketing application approved
广东恒健制药有限公司
CYHS2404576 · 国药准字H20266485
Fact date: 2026/11/03 · Publication date: 2026/11/05 · Site observation date: 2026/11/06
The loaded NHSA codes and chemical-drug catalogue contain no evidence confirming an earlier same-name approval for this company. This does not establish the absence of an earlier approval.
View source · Table row 16 ↗ -
2026/10/27Accepted
江苏润邦药业有限公司;中山万汉制药有限公司
CYHB2601964
Fact date: 2026/10/27 · Site observation date: 2026/10/28
View source ↗ -
2026/10/27Accepted
江苏润邦药业有限公司;中山万汉制药有限公司
CYHB2601963
Fact date: 2026/10/27 · Site observation date: 2026/10/28
View source ↗ -
2026/10/23No longer listed under review
山东华铂凯盛生物科技有限公司;烟台鲁银药业有限公司
CYHB2600880
Fact date: 2026/10/23 · Site observation date: 2026/10/23
Accepted: 2026/05/08
not on the CDE under-review list in this snapshot; NMPA published notification delivery for this acceptance number on 2026/10/22; the notification contents are not public and the outcome remains unverified; this is a supplemental application, not counted as a new marketing approval · NMPA source · row 5
NMPA · Table row 5 ↗ View source ↗ -
2026/10/23No longer listed under review
山东华铂凯盛生物科技有限公司;烟台鲁银药业有限公司
CYHB2600879
Fact date: 2026/10/23 · Site observation date: 2026/10/23
Accepted: 2026/05/08
not on the CDE under-review list in this snapshot; NMPA published notification delivery for this acceptance number on 2026/10/22; the notification contents are not public and the outcome remains unverified; this is a supplemental application, not counted as a new marketing approval · NMPA source · row 4
NMPA · Table row 4 ↗ View source ↗ -
2026/10/23No longer listed under review
山东华铂凯盛生物科技有限公司;烟台鲁银药业有限公司
CYHB2600878
Fact date: 2026/10/23 · Site observation date: 2026/10/23
Accepted: 2026/05/08
not on the CDE under-review list in this snapshot; NMPA published notification delivery for this acceptance number on 2026/10/22; the notification contents are not public and the outcome remains unverified; this is a supplemental application, not counted as a new marketing approval · NMPA source · row 3
NMPA · Table row 3 ↗ View source ↗ -
2026/10/23No longer listed under review
山东华铂凯盛生物科技有限公司;烟台鲁银药业有限公司
CYHB2600877
Fact date: 2026/10/23 · Site observation date: 2026/10/23
Accepted: 2026/05/08
not on the CDE under-review list in this snapshot; NMPA published notification delivery for this acceptance number on 2026/10/22; the notification contents are not public and the outcome remains unverified; this is a supplemental application, not counted as a new marketing approval · NMPA source · row 2
NMPA · Table row 2 ↗ View source ↗ -
2026/10/22Notification delivery
山东华铂凯盛生物科技有限公司
CYHB2600880
Fact date: 2026/10/22 (Publication date) · Publication date: 2026/10/22 · Site observation date: 2026/11/03
Notification delivered; the specific outcome remains to be checked.
View source · Table row 5 ↗ -
2026/10/22Notification delivery
山东华铂凯盛生物科技有限公司
CYHB2600879
Fact date: 2026/10/22 (Publication date) · Publication date: 2026/10/22 · Site observation date: 2026/11/03
Notification delivered; the specific outcome remains to be checked.
View source · Table row 4 ↗ -
2026/10/22Notification delivery
山东华铂凯盛生物科技有限公司
CYHB2600878
Fact date: 2026/10/22 (Publication date) · Publication date: 2026/10/22 · Site observation date: 2026/11/03
Notification delivered; the specific outcome remains to be checked.
View source · Table row 3 ↗ -
2026/10/22Notification delivery
山东华铂凯盛生物科技有限公司
CYHB2600877
Fact date: 2026/10/22 (Publication date) · Publication date: 2026/10/22 · Site observation date: 2026/11/03
Notification delivered; the specific outcome remains to be checked.
View source · Table row 2 ↗ -
2026/09/24Accepted
杭州民生健康药业股份有限公司;浙江赛默制药有限公司
CYHB2601814
Fact date: 2026/09/24 · Site observation date: 2026/10/22
View source ↗ -
2026/09/24Accepted
杭州民生健康药业股份有限公司;浙江赛默制药有限公司
CYHB2601813
Fact date: 2026/09/24 · Site observation date: 2026/10/22
View source ↗ -
2026/09/11Accepted
湖南科瑞生物制药股份有限公司;浙江浙北药业有限公司
CYHB2601726
Fact date: 2026/09/11 · Site observation date: 2026/10/22
View source ↗ -
2026/09/11Accepted
湖南科瑞生物制药股份有限公司;浙江浙北药业有限公司
CYHB2601725
Fact date: 2026/09/11 · Site observation date: 2026/10/22
View source ↗ -
2026/09/03Accepted
-
2026/09/03Accepted
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/10 07:27
- Chemical-drug catalogue
- Last successful update: 2026/11/10 07:23
Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
- Full API register
- Last successful update: 2026/11/10 07:25
- NHSA drug codes
- Last successful update: 2026/11/05 06:45
The fully loaded edition was maintained to 2026-10-23. Publication lags maintenance: the verified 2026-10-16 edition was published on 10-28, a 12-day gap. This is not a fixed lag for every edition.
- NMPA drug delivery notices
- Last successful update: 2026/11/10 18:31
First index-page publication dates: 2026-10-26 to 2026-11-10; 0 pages pending. Covers loaded notices only, not a complete historical approval database.
- Drug Clinical Trial Registry and Information Disclosure Platform
- Last successful update: 2026/11/10 08:10 · Current coverage may be incomplete
Daily collection reads new registrations. Backfill covers registration numbers from 2025 onward (CTR2025/CTR2026), not first-publication years. States are dated observations; revisions are not tracked.
This product is outside the trial-registration backfill scope. New registrations after daily collection started remain in scope. Historical rows may also be found by another product search; neither implies complete historical coverage for this product.
Public-product searches scanned: 3/30; discovered pending details: 20. Record counts in unscanned portions remain unknown.
Filings are counted by acceptance number and filing companies by first applicant. Strengths may have separate applications. Drug names are normalized only for width and whitespace; distinct generic names, dosage forms and combinations remain separate. Unstated strengths are marked. Company counts from different sources must not be added together.
Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Free follow
Follow changes to this drug
Up to 3 drugs per email address, in one weekly digest. Starts after email confirmation; unsubscribe at any time.
Subscriptions
Next-day facts and deliverable timelines
- One email the next day when new facts are collected for your followed products.
- Export the complete loaded event timeline for each followed product as CSV.
- Add up to 4 additional recipients, each confirmed by email.
- Increase your follow limit from 3 to 10 products.
Quarterly
US$540
Billed every three months
US$180 per month
Yearly
US$1,920
Billed every year
US$160 per month
Online subscriptions are not enabled. The form below registers interest; it does not charge or activate access.
Separate one-time purchase
US Orange Book × China records comparison
Full table and CSV export for 12 months from payment, with monthly data updates. No automatic renewal.
Subscriptions and comparison-table access are purchased separately. Neither includes the other.
US$490
One payment · 12 months of access
Online comparison-table purchase is not enabled.
Billed by Creem, our merchant of record · Terms · Refund policy